Concepedia

F. Casset‐Semanaz

FC

Statistics

Publications

4

Citations

174

H-Index

4

Active since

1998

Affiliations

Merck Serono (Switzerland)(Current)

F. Casset‐Semanaz is an author at Merck Serono (Switzerland) specializing in clinical trials, immunology, and neuroimmunology.

Top concepts

Publications per year

1998–2013

4

Publications

4

Safety and immunogenicity of a new formulation of interferon β-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results

Gavin Giovannoni, F. Casset‐Semanaz, John King et al. · Multiple Sclerosis Journal · 2008 · 68 citations

Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif (R) new formulation) in a phase IIIb study in patients with relapsing multiple sclerosis: 96-week results

James Simsarian, О. Л. Барбараш, F. Casset‐Semanaz et al. · 2008 · 44 citations

, , +10

On‐demand treatment of gastro‐oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

Jean–Paul Galmiche, G.Y. Shi, Bernd Simon et al. · Alimentary Pharmacology & Therapeutics · 1998 · 37 citations · Full text

Efficacy of subcutaneous interferon  -1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes

Nicola De Stefano, Giancarlo Comi, Ludwig Kappos et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 25 citations · Full text

1–4 of 4